The Executive Medical Director (EMD) role is generally assigned to be responsible for overseeing 2 or more programs, providing oversight/guidance/mentoring to the Medical Directors and Clinical Development Scientists on the teams, serving on cross-asset strategic teams (e.g., Renal strategy team) and providing input to strategic decisions at the Renal Strategy Team and Global Medicine Team meetings.
Managerial responsibilities over Senior Director, Medical Director Clinical Development directly and may support / oversees other Medical Directors/Clinical Development Scientists that report directly to the Executive Medical Director. Reports to VP, Clinical Development Hematology and Nephrology.
The EMD will support development of regulatory strategy, therapeutic area and other functional strategies.
The EMD is a specialized role and is specifically designated to provide medical leadership and input to Program Teams during the early to late stage of drug development (i.e., transitioning molecule through IND/CTA and First-in-Human study stage to Proof-of-Concept and End-of-Phase-2 stage and beyond). The incumbent will serve as one of the medical experts for the study team(s) and may serve as the medical monitor for clinical trials as necessary.
In line with its seniority, the EMD is typically responsible for multiple clinical development programs in a therapeutic area spanning IND to POC/Phase 2/3 under the supervision of a VP Clinical Development TA Head. In addition, she/he may also have responsibility for discrete, specific business development efforts (e.g., a due diligence on a specific target) and keep close ties with the Discovery and Research organizations.
Basic Qualifications
- An MD, or other equivalent medical degree from an accredited university with specialty training in Renal or related area.
- Minimum of 7 years relevant experience within pharma.
Strong business acumen: including in-depth knowledge of the multidisciplinary functions involved in a company's drug development process, e.g., clinical operations, biostatistics, regulatory, commercial operations, etc. and can proactively integrate multiple perspectives into the clinical development process for best end-results
Ability to prioritize multiple tasks and goals to ensure completion in a timely manner within budget
Ability to think both strategically and tactically
Advanced knowledge of the assigned therapy area is desired, with the capability to interpret, discuss and represent trial or program level data
At Alexion, you will find a collaborative culture that encourages innovation and a diverse environment where your contributions are valued. You will have the opportunity to be at the forefront of rare disease research and make a meaningful difference in patients' lives.
Ready to lead and inspire?
Apply now and take the first step towards a fulfilling career at Alexion, AstraZeneca Rare Disease.
Location: Seaport Boston
Date Posted
13-Nov-2024Closing Date
19-Nov-2024Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.